0001801170-23-000040.txt : 20230608 0001801170-23-000040.hdr.sgml : 20230608 20230608070030 ACCESSION NUMBER: 0001801170-23-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230605 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOVER HEALTH INVESTMENTS, CORP. /DE CENTRAL INDEX KEY: 0001801170 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 981515192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39252 FILM NUMBER: 231000671 BUSINESS ADDRESS: STREET 1: 3401 MALLORY LANE, SUITE 210 CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: (201) 432-2133 MAIL ADDRESS: STREET 1: 3401 MALLORY LANE, SUITE 210 CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: CLOVER HEALTH INVESTMENTS, CORP. DATE OF NAME CHANGE: 20210107 FORMER COMPANY: FORMER CONFORMED NAME: Social Capital Hedosophia Holdings Corp. III DATE OF NAME CHANGE: 20200124 8-K 1 clov-20230605.htm 8-K clov-20230605
FALSE0001801170CLOVER HEALTH INVESTMENTS, CORP. /DE00018011702023-06-052023-06-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 5, 2023

CLOVER HEALTH INVESTMENTS, CORP.

(Exact name of Registrant as Specified in Its Charter)

Delaware
001-3925298-1515192
(State or Other Jurisdiction
(Commission File Number)
(IRS Employer
of Incorporation)
Identification No.)
3401 Mallory Lane, Suite 210
Franklin, Tennessee
37067
(Address of Principal Executive Offices)(Zip Code)

Registrant’s Telephone Number, Including Area Code: (201) 432-2133

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:

Trading
Title of each class
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per shareCLOVThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 5, 2023, Joseph Martin notified Clover Health Investments, Corp. (the “Company”) that he will be resigning as General Counsel and Corporate Secretary of the Company, effective as of June 16, 2023, in order to pursue a new role at a public company.

“Joe has been a fantastic partner in helping steer us during this formative time as a young public company. I’m always delighted that we produce such fantastic Clover alumni and I think Joe has a wonderful opportunity in front of him” said Andrew Toy, Chief Executive Officer of the Company.

“I’ve enjoyed and appreciate my time spent with Clover and continue to deeply believe in its mission to bring great healthcare to the underserved while making Medicare more sustainable to society. I’ll always be a Clover supporter and wish Andrew and the rest of the team all the best success.” said Joe Martin.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Clover Health Investments, Corp.
Date:June 8, 2023By:/s/ Scott J. Leffler
Name:Scott J. Leffler
Title:Chief Financial Officer


 EX-101.SCH 2 clov-20230605.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 clov-20230605_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 4 clov-20230605_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Jun. 05, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 05, 2023
Entity Registrant Name CLOVER HEALTH INVESTMENTS, CORP. /DE
Entity Incorporation, State or Country Code DE
Entity File Number 001-39252
Entity Tax Identification Number 98-1515192
Entity Address, Address Line One 3401 Mallory Lane
Entity Address, Address Line Two Suite 210
Entity Address, City or Town Franklin
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37067
City Area Code 201
Local Phone Number 432-2133
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol CLOV
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001801170
XML 6 clov-20230605_htm.xml IDEA: XBRL DOCUMENT 0001801170 2023-06-05 2023-06-05 false 0001801170 CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K 2023-06-05 DE 001-39252 98-1515192 3401 Mallory Lane Suite 210 Franklin TN 37067 201 432-2133 false false false false Class A Common Stock, par value $0.0001 per share CLOV NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.cloverhealth/role/Cover Cover Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - clov-20230605.htm 4 clov-20230605.htm clov-20230605.xsd clov-20230605_lab.xml clov-20230605_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clov-20230605.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "clov-20230605.htm" ] }, "labelLink": { "local": [ "clov-20230605_lab.xml" ] }, "presentationLink": { "local": [ "clov-20230605_pre.xml" ] }, "schema": { "local": [ "clov-20230605.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "clov", "nsuri": "http://www.cloverhealth/20230605", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clov-20230605.htm", "contextRef": "i7b03a36b33e24ee2b9066e0bd1aa2240_D20230605-20230605", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.cloverhealth/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clov-20230605.htm", "contextRef": "i7b03a36b33e24ee2b9066e0bd1aa2240_D20230605-20230605", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cloverhealth/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001801170-23-000040-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001801170-23-000040-xbrl.zip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end